Supriya Lifescience - Quaterly Results

07 Nov 2023 Evaluate
The Revenue for the quarter ended  September 2023 of Rs. 1400.95 millions grew by 24.89 % from Rs. 1121.72 millions.A comparatively good net profit growth of 41.64% to Rs. 238.84 millions was reported for the quarter ended September 2023 compared to Rs. 168.62 millions of previous same quarter.Operating profit surged to 342.19 millions from the corresponding previous quarter of 311.67 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1400.95 1121.72 24.89 2721.16 2135.27 27.44 4609.38 5300.49 -13.04
Other Income 24.67 26.05 -5.30 53.85 49.62 8.52 94.89 75.77 25.23
PBIDT 342.19 311.67 9.79 816.28 647.70 26.03 1383.87 2215.62 -37.54
Interest 4.60 7.75 -40.65 12.76 13.56 -5.90 30.84 41.98 -26.54
PBDT 337.59 303.92 11.08 803.52 634.14 26.71 1353.03 2173.64 -37.75
Depreciation 39.81 29.73 33.91 79.36 58.58 35.47 118.15 101.18 16.77
PBT 297.78 274.19 8.60 724.16 575.56 25.82 1234.88 2072.46 -40.41
TAX 58.94 105.57 -44.17 200.20 154.44 29.63 336.30 554.35 -39.33
Deferred Tax -26.44 0.91 -3005.49 15.19 3.91 288.49 29.49 32.46 -9.15
PAT 238.84 168.62 41.64 523.96 421.12 24.42 898.58 1518.11 -40.81
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 24.43 27.79 -12.09 30.00 30.33 -1.11 30.02 41.80 -28.18

Supriya Lifescience Share Price

728.65 -36.10 (-4.72%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.